help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sivan, E.
Right arrow Articles by Boden, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sivan, E.
Right arrow Articles by Boden, G.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 7 2338-2342
Copyright © 1998 by The Endocrine Society


From the Clinical Research Centers

Free Fatty Acids and Insulin Resistance during Pregnancy1

Eyal Sivan, Carol J. Homko, Paul G. Whittaker, E. Albert Reece, Xinhua Chen and Guenther Boden

Departments of Obstetrics/Gynecology (E.S., C.J.H., P.G.W., E.A.R.) and Medicine (X.C., G.B.), Temple University Hospital, Philadelphia, Pennsylvania 19140

Address all correspondence and requests for reprints to: Guenther Boden, M.D., Temple University Hospital, 3401 North Broad Street, Philadelphia, Pennsylvania 19140.

The purpose of this study was to determine whether elevation of plasma free fatty acids (FFA) in early pregnancy would cause alterations in insulin-stimulated glucose disposal similar to those occurring in late gestation. Seven glucose-tolerant women underwent 4-h euglycemic hyperinsulinemic (1 mU/kg·min) clamping during the early second trimester of pregnancy (14–17 weeks) on 2 consecutive days, receiving either lipid (Liposyn II; 1.5 mL/min) and heparin (0.4 U/kg·min; L/H) or saline/glycerol (2.25 g/h; S/G) infusions. Rates of total body glucose disposal (6,6-2H2 glucose) and of carbohydrate and fat oxidation (indirect calorimetry) were determined at hourly intervals. Blood glucose was clamped at about 85 mg/dL. Plasma FFA increased from 290 ± 50 to 1000 ± 139 µmol/L during L/H infusion and decreased from 351 ± 60 to 35 ± 11 µmol/L during S/G infusion. L/H infusion inhibited insulin stimulation of total body glucose disposal by 28% compared with S/G infusion (from 6.7 ± 0.7 to 4.9 ± 0.6 mg/kg·min; P < 0.01). L/H infusion increased fat oxidation from 0.73 ± 0.04 to 1.26 ± 0.2 mg/kg·min (P < 0.05) and decreased carbohydrate oxidation from 2.0 ± 0.2 to 1.6 ± 0.2 mg/kg·min (P < 0.05). Endogenous glucose production decreased equally by approximately 70% during L/H and S/G infusions. These data showed that elevating plasma FFA levels during early pregnancy inhibits total body glucose uptake and oxidation. We conclude that elevation of plasma FFA can contribute to the peripheral insulin resistance commonly observed during late pregnancy.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
B. Vistisen, L. I Hellgren, T. Vadset, C. Scheede-Bergdahl, J. W. Helge, F. Dela, and B. Stallknecht
Effect of gender on lipid-induced insulin resistance in obese subjects
Eur. J. Endocrinol., January 1, 2008; 158(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. J. Homko, P. Cheung, and G. Boden
Effects of Free Fatty Acids on Glucose Uptake and Utilization in Healthy Women
Diabetes, February 1, 2003; 52(2): 487 - 491.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. P. Frias, G. B. Macaraeg, J. Ofrecio, J. G. Yu, J. M. Olefsky, and Y. T. Kruszynska
Decreased Susceptibility to Fatty Acid-Induced Peripheral Tissue Insulin Resistance in Women
Diabetes, June 1, 2001; 50(6): 1344 - 1350.
[Abstract] [Full Text]


Home page
Diabetes CareHome page
M. Blüher, J. Kratzsch, and R. Paschke
Plasma Levels of Tumor Necrosis Factor-{alpha}, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose Tolerance
Diabetes Care, February 1, 2001; 24(2): 328 - 334.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society